The Government of India has launched Production Linked Incentive Scheme for Pharmaceuticals to promote domestic manufacturing of critical key starting materials (KSMs), Active Pharma Ingridients and Drug Intermediates (DIs). The scheme has an outlay of Rs.6,940 crore and the scheme also provides financial incentive to the participants on incremental sales of 41 identified products in 4 target segments for six years.
The scheme was approved in March, 2021 to enhance Pharma manufacturing capabilities by increasing production and investment in Pharma sector which will contribute to product diversification to high value goods in pharma sector. Fifty applicants have been approved under the PLI Scheme for Bulk Drugs while fifty five applicants have been approved under the PLI scheme for Pharma.
Both these schemes are available at:pharmaceuticals.gov.in, informed Mansukh Mandaviya, Minister of Chemicals and Fertilizers while giving a written reply in Rajya Sabha.